Mr. Ghobry joined BI – London as Director, Brand Development in 2011 and was promoted to Vice President, Brand Development in 2013 and more recently to President, London in 2014. Prior to joining BI, he was a manager of a multi-national retail Pharmacy chain and clinical pharmacist by training. Mr. Ghobry earned his MPharm from the UCL School of Pharmacy and is a member of the Royal Pharmaceutical Society of Great Britain. Mr. Ghobry has led over 500 Brand Naming, Brand Architecture and Nonproprietary naming projects during his tenure with Brand Institute. Brand naming initiatives that Mr. Ghobry led include Fasenra (AstraZeneca), Fetroja (Shionogi), Nyxoid (Mundipharma), Restasis (Allergan) and Nucala (GSK).
